Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01218_DB06708_nanopub.RAajih4WqAHd3Xy9aR1zjmoIYpEmIX0b8wCvGJQjYcO-w#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01218_DB06708 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01218_DB06708 label "DDI between Halofantrine and Lumefantrine - Halofantrine may increase the adverse effects of lumefantrine. Additive QTc-prolongation may occur. Combination therapy is contraindicated and therapies should not be administered within one month of each other due to the long half-life of lumefantrine. [drugbank_resource:DB01218_DB06708]" assertion.
- drugbank_resource:DB01218_DB06708 identifier "drugbank_resource:DB01218_DB06708" assertion.
- drugbank_resource:DB01218_DB06708 title "DDI between Halofantrine and Lumefantrine - Halofantrine may increase the adverse effects of lumefantrine. Additive QTc-prolongation may occur. Combination therapy is contraindicated and therapies should not be administered within one month of each other due to the long half-life of lumefantrine." assertion.
- drugbank:DB06708 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01218_DB06708 assertion.
- drugbank:DB01218 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01218_DB06708 assertion.